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CD271-selected mesenchymal stem 
cells from adipose tissue enhance 
cartilage repair and are less 
angiogenic than plastic adherent 
mesenchymal stem cells
Nupur Kohli1,2, Ibtesam R. T. Al-Delfi1,3, Martyn Snow4, Takumi Sakamoto5, 
Tsuyoshi Miyazaki5, Hideaki Nakajima5, Kenzo Uchida5 & William E. B. Johnson1,6
CD271 is a marker of bone marrow MSCs with enhanced differentiation capacity for bone or cartilage 
repair. However, the nature of CD271+ MSCs from adipose tissue (AT) is less well understood. Here, 
we investigated the differentiation, wound healing and angiogenic capacity of plastic adherent MSCs 
(PA MSCs) versus CD271+ MSCs from AT. There was no difference in the extent to which PA MSCs 
and CD271+ MSCs formed osteoblasts, adipocytes or chondrocytes in vitro. In contrast, CD271+ 
MSCs transplanted into athymic rats significantly enhanced osteochondral wound healing with 
reduced vascularisation in the repair tissue compared to PA MSCs and control animals; there was little 
histological evidence of mature articular cartilage formation in all animals. Conditioned medium from 
CD271+ MSC cultures was less angiogenic than PA MSC conditioned medium, and had little effect 
on endothelial cell migration or endothelial tubule formation in vitro. The low angiogenic activity of 
CD271+ MSCs and improved early stage tissue repair of osteochondral lesions when transplanted, 
along with a comparable differentiation capacity along mesenchymal lineages when induced, suggests 
that these selected cells are a better candidate than PA MSCs for the repair of cartilaginous tissue.
Regenerative medicines using stem cells and/or tissue engineering approaches are expected to play a major role in 
the development of new healthcare in the 21st century, with much current interest and research activity. However, 
a major problem to this approach, especially if using autologous stem cells sourced from adult tissues remains 
in optimising which cells are best applied for different pathological conditions and tissues. An example of this 
can be found in the development of treatment strategies for osteochondral defects, which is problematic as the 
damage extends to the subchondral bone and the repair responses demands the healing and reformation of two 
connective tissue types, i.e. cartilage and bone1,2. Current surgical treatment include the use of osteochondral 
auto/allografts, which often lead to poor subchondral bone regeneration with superficial fibrocartilage forma-
tion3–5. Repairing osteochondral damage by transplanting mesenchymal stromal/stem cells (MSCs), which have 
the capacity to differentiate into chondrocytes and osteoblasts forming new cartilage and bone, respectively, has 
shown some promise6–8. However, MSCs are often isolated from bone marrow, which can mean a painful opera-
tive procedure and morbidity9, and recent data suggests that rather than differentiating to form chondrocytes or 
osteoblasts, transplanted MSCs may repair tissues by exerting paracrine effects on endogenous cells to increase 
wound healing processes10,11, e.g. by stimulating angiogenic responses in bone, but not cartilage12,13. Hence, the 
1Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK. 2Regenerative Biomaterials Group, RAft 
Institute, Leopold Muller Building, Mount Vernon Hospital, Northwood, London, HA6 2RN, UK. 3Al-Toosi Private 
University College, Nursing Department, Al-Saad Quarter, Al-Muthanaa Street, Al-Najaf, Iraq. 4Royal Orthopaedic 
Hospital NHS Foundation Trust, Birmingham, B31 2AP, UK. 5Department of Orthopaedics and Rehabilitation 
Medicine, Faculty of Medical Sciences University of Fukui, Matsuoka Shimoaizuki, Eiheiji, Fukui, Japan. 6faculty 
of Medicine, Dentistry and Life Sciences, University of Chester, Chester, CH1 4BJ, UK. Kenzo Uchida is deceased. 
Correspondence and requests for materials should be addressed to W.E.B.J. (email: eustace.johnson@chester.ac.uk)
Received: 17 September 2018
Accepted: 25 January 2019
Published: xx xx xxxx
opeN
2Scientific RepoRts |          (2019) 9:3194  | https://doi.org/10.1038/s41598-019-39715-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
use of MSCs for the repair of deep cartilaginous wounds highlights how there is a need to optimise adult stem 
cell-based therapies as well as identify potential mechanisms of action.
For this reason, much current interest in MSC-based regenerative medicines has been examining defined 
subpopulations of MSCs from the heterogeneous pools of cells present in bone marrow and different tissue 
sources14–17. The cell surface markers CD73 and CD105 were reported to select bone marrow MSCs (BM MSCs) 
that have increased chondrogenic differentiation capacity compared to non-selected BM MSCs, which are rou-
tinely isolated based on their capacity to adhere to tissue culture plastic16,18. In addition, CD271 was proposed as a 
marker of BM MSCs with multi-potential differentiation capacity, but with increased capacity to form bone14,19–22. 
Alternative tissue sources of MSCs have also been investigated. Adipose tissue, in particular, is an attractive autol-
ogous source as it is often abundant in human adults and relatively easy to harvest compared to bone marrow23–25. 
However, whether adipose tissue-derived MSCs (AT MSCs) can form cartilage and bone is unclear, with research 
demonstrating reproducible differentiation along chondrocytic and osteogenic lineages in vitro, but with more 
uncertain results seen in vivo26–29. In addition, the properties of selected AT MSC subpopulations have been less 
extensively researched than BM MSCs, although two studies have reported that CD271-selected AT MSCs have 
an enhanced proliferative capacity compared with unsorted plastic adherent (PA MSCs), which is how MSCs are 
generally isolated from tissue harvests, with differentiation capacity to form chondrocyte-like cells, osteoblasts 
and adipocytes in vitro30,31. Importantly, whether CD271-selected AT MSCs have enhanced capacity to heal car-
tilage or bone defects, or differential paracrine wound healing activity, is currently unknown. Therefore, the aim 
of this study was to investigate the wound healing potential of AT MSCs selected on the basic of plastic adherence 
(PA MSCs) versus immunopositivity for CD271 (CD271+ MSCs) in a rodent model of osteochondral tissue 
damage, using a commercially available cell scaffold for cartilage repair as a delivery system8. In addition, we have 
examined the differentiation capacity and angiogenic activity of PA MSCs versus CD271+ MSCs in vitro.
Results
CD profiling and in vitro differentiation of PA MSCs and CD271+ MSCs. Culture-expanded PA 
MSCs and CD271+ MSCs showed immunopositivity for MSC specific cell-surface antigens, i.e., CD73, CD90 
and CD105, to a similar extent, and were immunonegative for haematopoietic markers, i.e., CD34 and CD45 
(Fig. 1A). These adherent cells were of stromal appearance and differentiated down the three mesodermal lin-
eages, as indicated by positive alkaline phosphatase staining for osteogenesis, positive Oil Red O staining of 
lipid vacuoles for adipogenesis and metachromatic toluidine blue staining of paraffin-sections of cell pellets for 
chondrogenesis (Fig. 1B). Significant increases (p < 0.001) were seen in the levels of alkaline phosphatase (ALP), 
Oil Red O accumulation and glycosaminoglycan (GAGs) secreted in differentiated cell cultures compared to 
undifferentiated cultures (Fig. 1C). There were no significant differences in the extent of PA MSC and CD271+ 
MSC differentiation, as delineated by these measures, and no obvious differences in PA MSC and CD271+ MSC 
numbers, as depicted through cell confluence or pellet size (and H&E staining of pellet sections); however, it will 
be important to normalise these differentiation outcome measures to confirmed cell numbers in future studies.
The effects of PA MSCs and CD271+ MSCs seeded Alpha Chondro Shield on cartilage repair: 
gross morphology at 3 weeks post-transplantation. SEM demonstrated that PA MSCs and CD271+ 
MSCs incorporated within a cell scaffold consisting of fibres of polyglycolic acid (PGA), called Alpha Chondro 
Shield, within 30 minutes of seeding. There was no difference between the prevalence of PA MSCs and CD271+ 
MSCs within the scaffold and both cell types showed firm attachment to the PGA fibres, with a few cells show-
ing a flattened morphology, although most remained rounded at this stage (Fig. 2A, upper panels). Therefore, 
this time point (30 minutes) was used to ensure cell adhesion and incorporation prior to implantation of the 
cell-seeded scaffolds into osteochondral defects that had been created simultaneously in athymic rats. Scaffolds 
were implanted alone also, i.e., in culture medium but without prior cell seeding, as a control. To confirm the 
biocompatibility of the Alpha Chondro Shield scaffold for MSC adhesion and growth, we performed SEM and 
LIVE/DEAD staining of the cell-seeded scaffolds after they had been maintained for 7 days and 28 days in vitro in 
culture medium. As shown (Fig. 2A, lower panels), both the PA MSCs and the CD271+ MSCs became fibroblas-
tic, remained adherent to the PGA fibres and proliferated to completely cover and fill the Alpha Chondro Shield 
scaffold; furthermore, there was no evidence of any cell death.
Gross examination of the osteochondral defects at 3 weeks post-transplantation revealed a well-integrated 
glossy white repair tissue in the defects transplanted with CD271+ MSCs, which appeared less vascularised, 
better integrated and with a greater defect fill (Fig. 2B, Table 1). In the defects transplanted with PA MSCs, a 
depressed repair tissue with distinct defect edges was observed. Moreover, the border area of the defect was 
clearly distinguishable and depressions were obvious in those lesions of the scaffold alone control group (Fig. 2B, 
Table 1). The animals transplanted with CD271+ MSCs had a significantly better overall macroscopic repair score 
(p < 0.05) compared to the animals transplanted with PA MSCs or with the Alpha Chondro Shield scaffold alone. 
Animals transplanted with CD271+ MSCs scored 5.0 ± 2.5, whereas those transplanted with PA MSCs scored at 
9.8 ± 1.7, and the control group was scored at 10.6 ± 1.5 (Fig. 2C) (means ± SD).
The effects of PA MSCs and CD271+ MSCs seeded Alpha Chondro Shield on cartilage repair: 
histological outcomes at 3 weeks post-transplantation. Defect fill, observed by H&E and toluidine 
blue staining, was greater in those defects that were transplanted with CD271+ MSCs compared to defects trans-
planted with PA MSCs (Fig. 3A, upper panels). A firm attachment of the scaffold to the underlying subchondral 
region or trabecular bone was seen in all cases. Defects transplanted with scaffold alone were infiltrated with a 
cell-rich fibrous tissue. The repair tissue within the defects that were transplanted with MSCs showed some local-
ised toluidine blue metachromasia, most notably for those animals transplanted with CD271+ MSCs, whereas 
the cell-rich fibrous tissue in the control animals transplanted with Alpha Chondro Shield scaffolds alone showed 
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no metachromasia (Fig. 3A, upper-mid panels). Immunolocalisation for human mitochondrial antigen (HMA) 
was observed to a similar extent in the repair tissues of the PA MSCs and CD271+ MSC transplanted animals, 
but was absent in the Alpha Chondro Shield alone control group (Fig. 3A, lower-mid panels). HMA-positive 
cells were detected embedded in the fibrous ECM surrounding the scaffold fibres. Due to the nature of mito-
chondrial staining, it was not possible to quantify the exact number of HMA-immunopositive cells. Animals 
transplanted with PA MSCs or the Alpha Chondro Shield alone showed a greater vascularisation within the 
repair tissue compared to the animals transplanted with CD271+ MSCs (Fig. 3A, lower panels). Scoring for his-
tological criteria demonstrated that in those animals transplanted with CD271+ MSCs there was a markedly and 
significantly greater thickness of defect fill with cartilaginous/fibrous tissue compared with those animals trans-
planted with the PA MSCs or the control group (p < 0.05) and significantly fewer blood vessels in the CD271+ 
MSC-transplanted group compared with those animals transplanted with the PA MSCs (p < 0.05), with little 
difference between groups seen in all other criteria (Table 2). Furthermore, there was a significant difference seen 
between the overall histological score for the CD271+ MSC transplanted group compared with the control group 
Figure 1. Differentiation and CD profiles of PA MSCs and CD271+ MSCs. (A) Both cell types showed 
immunopositivity for CD73, CD90 and CD105 and immunonegativity for CD34 and CD45. (B) PA MSCs and 
CD271+ MSCs show similar qualitative differentiation potential as represented by positive alkaline phosphatase 
staining (pink-red cells) for osteogenesis, positive Oil Red O staining of lipid droplets for adipogenesis (orange-
red droplets) and metachromatic toluidine blue staining of glycosaminoglycans (GAGs) for chondrogenesis. 
Scale bar = 100 µm. (C) Increased levels of alkaline phosphatase, Oil Red O and GAGs were secreted by both PA 
MSCs and CD271+ MSCs when induced to differentiate down the osteogenic, adipogenic and chondrogenic 
lineages, respectively, compared to the undifferentiated controls. Data shown are means ± SEMs of n = 3 for Oil 
Red O and GAGs levels; means ± SDs for ALP levels.
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(p < 0.01), which was not seen for the PA MSC transplanted group versus the control group (Fig. 3B). The overall 
histological scores for CD271+ MSCs transplanted animals was 9.2 ± 1.6; for PA MSC-transplanted animals was 
12.3 ± 2.1, and for the Alpha Chondro Shield alone control group was 14.3 ± 1.0 (means ± SD).
Figure 2. Gross morphology and the wound repair of defects. (A) Representative SEM images of cell-seeded 
Alpha Chondro Shield are shown. Both PA MSCs and CD271+ MSCs (red arrows) were attached to the fibres 
(yellow asterisks) of polyglycolic acid at 30 minutes post-seeding. The Alpha Chondro Shield scaffold alone control 
is also shown. With further time in culture (days 7 and 28), the PA MSCs and CD271+ MSCs became more 
fibroblastic in appearance and filled the scaffold. LIVE/DEAD staining was performed on long-term cultures, 
where all cells appeared to be viable (green fluorescence). Scale bars = 50 µm for top and bottom panel SEM; scale 
bars = 25 µm for mid panel SEM and LIVE/DEAD images. Insets (top panels) show high magnification images of 
cells firmly attached to the scaffold fibres. Inset scale bar = 10 µm. (B) Representative images are shown of the gross 
morphology of the defects transplanted with PA MSCs, CD271+ MSCs and Alpha Chondro Shield alone. Gross 
examination revealed a glossy white and well-integrated repair tissue in the animals that received CD271+ MSCs, 
but not in animals that received PA MSCs or Alpha Chondro Shield alone (control). (C) The overall macroscopic 
scores of defects transplanted with CD271+ MSCs were significantly better than the defects transplanted with PA 
MSCs (p value = 0.043) or control (p value = 0.039). Data shown are means ± SDs.
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In vitro paracrine angiogenic activity of PA MSCs and CD271+ MSCs. The stimulatory activity of 
conditioned medium from MSC cultures versus control (non-conditioned) medium on EA.hy926 endothelial 
cell migration and proliferation was determined using phase contrast microscopy and image analysis over time 
of scratch wound assays (Fig. 4A). The extent of wound closure was significantly reduced in conditioned medium 
from CD271+ MSC cultures compared to the effects of conditioned medium from PA MSC cultures (p < 0.01). In 
these scratch wound assays, the extent to which the original wound width had closed at 48 hours after scratching 
was 81.4 ± 3.2% in PA MSC conditioned medium, 58 ± 5.1% in CD271+ MSC conditioned medium, whilst only 
40.3 ± 6.7% in control medium (Fig. 4B). There was no significant difference in the original scratch wound widths 
at time 0 (data not shown). Matrigel assays of EA.hy926 endothelial tubule formation in MSC culture-conditioned 
medium versus control medium corroborated the angiogenic effects of the scratch assays, where significant increases 
(p < 0.001) in endothelial tubule length and the number of endothelial tubule branch points (also indicative of new 
blood vessel formation) were seen when EA.hy926 endothelial cells were maintained in PA MSC conditioned 
medium compared to either CD271+ MSC conditioned medium or control medium (Fig. 5A,B).
Discussion
CD271 selected MSCs from various sources including BM32, AT30,33 and synovium18 have shown potential for 
their use in regenerative medicine. In vitro studies suggest that isolating cells that are immune-positive for CD271 
results in a homogenous population that also co-expresses CD73, CD90 and CD10518,32,34. CD271+ MSCs from 
BM have previously been shown to give rise to superior cartilage formation in vivo compared to PA MSCs35. Here, 
osteochondral  defects transplanted with AT derived CD271+ MSCs showed macroscopically superior repair 
Macroscopic parameter PA MSCs CD271+ MSCs Control
Colour of the repair tissue 2.3 ± 0.5 1.3 ± 0.8 2.3 ± 0.6
Blood vessels in the repair tissue 1.7 ± 0.8 0.8 ± 0.8* 2.7 ± 0.6
Surface of the repair tissue 2.2 ± 0.4 1.2 ± 0.4** 2.0 ± 0.0
Defect fill 1.7 ± 0.5 0.5 ± 0.5* 1.3 ± 0.6
Degeneration of adjacent cartilage 2.0 ± 0.6 1.3 ± 0.5 2.3 ± 0.6
Table 1. Macroscopic scores for individual parameters of cartilage repair. Bold text indicates statistical significant 
differences with asterisks displayed on the lower scores. Data shown are means ± SDs. * < 0.05; ** < 0.01.
Figure 3. Histological assessment of the cartilaginous repair tissue. (A) Representative images are shown 
of the tissue sections of rat knees stained with haematoxylin and eosin (H&E), toluidine blue and following 
immunolocalisation for human mitochondrial antigen (HMA). A greater extent of defect fill with areas of 
prominent metachromatic staining of GAG deposition was observed in the defects transplanted with CD271+ 
MSCs compared to defects transplanted with PA MSCs and the Alpha Chondro Shield scaffold alone. The 
presence of human cells was confirmed by immunolocalization of HMA as indicated by brown punctate 
staining (red arrows) around the PGA fibres (yellow asterisks) of the scaffold in the cell-treated groups, but not 
in scaffold alone group. Greater vascularisation was seen in the defects transplanted with PA MSCs and the 
Alpha Chondro Shield scaffold alone compared to defects transplanted with CD271+ MSCs. Scare bars: H&E 
top row and toluidine blue = 200 µm; HMA = 10 µm; H&E bottom row = 50 µm. (B) There was a significantly 
lower overall histological score, indicative of better repair tissue, in defects transplanted with CD271+ MSCs 
compared with the control group. Data shown are means ± SDs. **p < 0.01.
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tissue compared to defects transplanted with PA MSCs and the control group of scaffold alone. Histologically, all 
defects showed fibrous cartilaginous repair tissue, but localised metachromatic toluidine blue staining was seen 
more prominently in the repair tissue of defects treated with CD271+ MSCs. In addition, there was a significantly 
Histological parameter PA MSCs CD271+ MSCs Control
Cell morphology 2.0 ± 0.0 2.0 ± 0.0 3.0 ± 0.0
Matrix staining 1.5 ± 0.5 1.7 ± 0.5 2.0 ± 0.0
Surface regularity 1.3 ± 0.5 1.5 ± 0.5 1.7 ± 0.5
Thickness 1.0 ± 0.6 0.0 ± 0.0* 1.3 ± 0.5
Integration 0.7 ± 0.5 0.3 ± 0.5 0.5 ± 0.6
Blood vessels 3.7 ± 0.5 1.2 ± 0.7* 3.2 ± 0.5
Foreign body giant cells 2.2 ± 0.7 2.3 ± 1.2 2.8 ± 0.5
Table 2. Histological scores of individual parameters for cartilage repair. The histological scores for all criteria in the 
different experimental groups, where 0 = “best repair” and 4 = “worst repair”. The scores for defect fill (thickness) 
was significantly different in the CD271+ MSC-transplanted group compared to the PA MSC-transplanted group 
and the control group. Furthermore, there were significantly fewer blood vessels present in the repair tissue of the 
CD271+ MSC-transplanted animals compared with the PA MSC-transplanted animals. Bold text indicates statistical 
significant differences, with the asterisks displayed on the lower scores. Data shown are means ± SDs. * < 0.05
Figure 4. The effects of conditioned medium from PA MSCs and CD271+ MSCs on EA.hy926 endothelial 
cell migration. (A) Live cell imaging was used to determine the rate of endothelial cell migration in scratch 
assays in PA MSC conditioned medium versus CD271+ MSC conditioned medium and non-conditioned 
control medium. As shown, there was a significant increase in endothelial migration in PA MSC conditioned 
medium versus both other groups, with CD271+ MSC conditioned medium proving no greater than control 
conditions. (B) This difference in endothelial cell migration was further evidenced by the rate of wound closure 
in these scratch assays, where the rate of closure in CD271+ MSC conditioned medium was significantly slower 
compared with the PA MSC conditioned medium (p < 0.01). Data shown are means ± SEMs.
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greater fill of cartilaginous/fibrous tissue formed in the defect area after CD271+ MSC transplantation, which 
was markedly less vascularised than that formed after PA MSC transplantation or in control (scaffold alone) 
animals. Furthermore, only CD271+ MSC-transplanted animals had an overall histological score that was signif-
icantly different to that of control animals. These data suggest that CD271+ MSCs from adipose tissue, similar to 
CD271+ MSCs from bone marrow, are better candidate cells for the promotion of cartilage repair.
For complete healing of full-thickness osteochondral defects, it is essential that the trabecular and subchon-
dral bones also are fully restored in addition to resurfacing of the lesion with articular cartilage. Therefore, it 
is advantageous for transplanted candidate cell type(s) to have the ability to differentiate to form bone- and 
cartilage-forming cells. Our analysis of MSC differentiation in vitro suggested that PA MSCs and CD271+ MSCs 
from AT had a similar capacity to become osteoblasts or chondrocytes. However, although there were no sig-
nificant differences in the extent of PA and CD271+ MSC differentiation, as delineated by alkaline phosphatase 
activity, Oil Red O accumulation, or the release of GAGs, it will be important to normalise these differentiation 
outcome measures to confirmed cell numbers in future. More importantly, in both cell transplantation animal 
groups there was little evidence of mature hyaline cartilage or new bone formation. In addition, after staining 
for the human mitochondrial antigen (HMA) in the excised osteochondral tissues, to identify the presence of 
transplanted human MSCs in the rats, there was no evidence of HMA immunopositive cells being encased in 
hyaline-like cartilage or in bone, where instead HMA-positive cells were seen in fibrous tissues and around the 
PGA scaffold material. This suggests that neither the transplanted PA MSCs nor the transplanted CD271+ MSCs 
differentiated to form mature chondrocytes or osteoblasts.
The lack of evident transplanted MSC differentiation in vivo could be due to an early time point of analysis, 
i.e., at 3 weeks post-transplantation and further research is required to examine the long-term fate of these cells. 
Wakitani et al., have previously listed the sequence of events that are likely to take place following transplantation 
of cell-scaffolds into a full thickness defect36. In rats, such osteochondral lesions heal without intervention within 
6–8 weeks28,37–40. Wakitani et al. hypothesized that vascular infiltration into the defect causes host-derived MSCs 
to undergo osteogenesis and restore the osseous tissue. This happens only up to the natural junction between the 
host cartilage and subchondral bone, as the distal part of the defect is under the influence of factors present in the 
synovial cavity where the osteochondral progenitor cells give rise to the cartilage36. The fact that there was little 
evidence of mature hyaline-like cartilage in either of the MSC transplanted groups also may be due to our use 
of subcutaneous AT as a cell source. Mochizuki and co-workers reported that subcutaneous AT is not a suitable 
source of MSCs for cartilage repair as subcutaneous AT MSCs have lower chondrogenic potential compared 
to synovium-derived MSCs39. In addition, in a donor-matched comparison, infrapatellar fat pad MSCs were 
reported to have a higher chondrogenic potential than subcutaneous AT MSCs40.
The differences in the effects of PA MSCs and CD271+ MSCs on cartilage repair may be associated with dif-
ferences in angiogenesis. AT MSCs have previously been shown to secrete angiogenic factors that are inhibitory 
Figure 5. The effects of conditioned medium from PA MSCs and CD271+ MSCs on EA.hy926 endothelial cell 
tubule formation. (A) There was greater formation of tubule-like structures when EA.hy926 cells were treated 
with PA MSC conditioned medium compared to CD271+ MSC conditioned medium and non-conditioned 
control medium. (B) There was a significant difference (p < 0.001) in tubule length and branch points/image 
formed by EA.hy926 endothelial cells when treated with PA MSC conditioned medium compared to CD271+ 
MSC conditioned medium and non-conditioned control medium. Data shown are means ± SEMs.
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to cartilage-like ECM deposition28. In the current study, vascular invasion was seen in the repair tissue of both of 
the MSC-treated groups as well as the scaffold-alone transplanted group, which may have prevented hyaline-like 
ECM deposition. However, the CD271+ MSC transplanted group contained a comparatively and significantly 
lower number of blood vessels compared to PA MSCs and the control group. Other studies also have previously 
shown that articular cartilage GAGs inhibit endothelial cell adhesion and migration41–43. It may be that CD271+ 
MSCs induced an early cartilage-like repair response comprising of GAGs that inhibit blood vessel formation, 
whereas PA MSCs did not induce the deposition of GAGs.
To explore further the differences seen in the blood vessel invasion of the repair tissue formed in 
MSC-transplanted osteochondral lesions, we examined the comparative effects of conditioned medium from PA 
MSCs and CD271+ MSCs versus non-conditioned control medium on EA.hy926 endothelial cells in vitro. Our 
data demonstrates that PA MSCs secreted factors into culture that were angiogenic, promoting endothelial cell 
migration and tubule formation, whilst conditioned medium from CD271+ MSC cultures did not. These findings 
are consistent with our in vivo data and support the conclusion that CD271+ MSCs are less angiogenic than PA 
MSCs. Furthermore, the data supports the suggestion that implanted CD271+ MSCs may have enhanced carti-
laginous wound repair through MSC-mediated ECM deposition, albeit mostly fibrous in nature, whilst having 
little angiogenic effect on endothelial cells. Previous studies have reported that MSCs can act as therapeutic agents 
through their secretion of trophic factors that encourage host progenitor cells to undergo tissue regeneration44. 
Indeed, MSCs secrete factors that are both angiogenic, e.g. vascular endothelial growth factors, fibroblast growth 
factors and fibronectin10–14, and also that inhibit endothelial cells and blood vessels formation, e.g. aggrecan42,43; 
therefore further study is required to examine the relative levels of these secreted factors in conditioned medium 
from PA MSCs in comparison to CD271+ MSCs.
In conclusion, our data shows that PA MSCs and CD271+ MSCs demonstrate similar MSC-like properties, 
in terms of differentiation capacity, which supports their use in cell-based therapies. However, selective isolation 
of CD271+ MSCs from adipose tissue results in the culture expansion of a subset of cells that are less angiogenic 
and were better able to promote cartilage repair of osteochondral tissue damage. Therefore, the transplantation of 
CD271+ MSCs may be more favoured for the restoration of mature, avascular tissues such as articular cartilage.
Methods
All methods in human and animal studies were performed in accordance with the relevant institutional guide-
lines and regulations.
Isolation and culture of plastic adherent MSCs and CD271 immunopositive MSCs from adipose 
tissue. Following ethical approval from the National Health Service (NHS) Health Research Authority (LREC 
number 12/EE/0136) and informed consent from all donors, PA MSCs and CD271+ MSCs were isolated from 
AT that had been harvested as surgical waste products. The AT was minced and treated with 0.3 U/ml of col-
lagenase (Sigma, Dorset UK) for two hours at 37 °C after which Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 20% (v/v) fetal calf serum (FCS) and 1% (v/v) penicillin and streptomycin (All from PAA, 
Yeovil, Somerset, UK) was added and the digested preparation centrifuged at 600 g for 10 minutes. The resulting 
pellet was re-suspended in DMEM supplemented with 10% (v/v) FCS and 1% (v/v) penicillin and streptomycin, 
i.e., standard culture medium and passed through a 100 μm cell strainer (BD Biosciences, Berkshire, UK). The 
filtrate was re-centrifuged at 600 g for 10 minutes and pelleted cells re-suspended in 5 ml standard culture medium 
and passed through a 40 μm cell strainer. The resulting cell suspension was then treated with Erythrocyte Lysis 
Buffer (Miltenyi Biotech, Surrey, UK) for 10 minutes at room temperature. For each AT preparation, MSCs were 
isolated from the mononucleated cells present after erythrocyte lysis through their increased adhesion to tissue 
culture plastic8 or by magnetic associated cell sorting (MACS) for CD271 immunopositivity14. These cells were 
culture expanded in standard culture medium in a humidified atmosphere at 37 °C with routine passaging by 
trypsinisation at 80% confluence. PA MSCs and CD271+ MSCs at passages II-III were used for all subsequent 
experimentation. Flow cytometry was used to assess the enrichment for CD271+ cells (using MACS technology), 
where the freshly isolated cells were stored at −80 °C overnight after isolation, and then thawed and immediately 
immunostained for CD271; for all samples, >90% of cells were CD271 immunopositive at this time point (data 
not shown).
In vitro differentiation protocols. The differentiation capacity of PA and CD271+ MSCs to form osteo-
cytes, chondrocytes and adipocytes was assessed as described previously8,45. Briefly, for osteogenesis, monolayer 
cultures of MSCs were treated with 10 nM dexamethasone, 50 ng/ml ascorbic acid and 1 mM beta glycerophos-
phate (versus carrier controls) every 2–3 days for a period of 4 weeks, after which the cultures were harvested 
by fixation and stained for alkaline phosphatase activity as follows: cells were fixed with 10% neutral buffer 
formalin for 10 minutes. Meanwhile, staining solution was prepared by placing 25 mg of naphthol-phosphate 
(Naphthol AS-MX phosphate: Sigma) in 0.5 ml of dimethyl formamide. This solution was mixed with 50 ml of 
0.2 M Tris-HCl buffer containing 50 mg of fast red TR (Sigma). After mixing well, the final solution was filtered 
using Whatman No. 1 filter paper (Whatman). The fixative solution was then removed and cells were washed 
with PBS, then 1 ml of the staining solution was added to each well for 1 hr. Finally, the stain was removed and 
digitized images were captured with an inverted microscope. Differentiation along the osteogenic lineage was 
further evaluated by increased amount of alkaline phosphatase activity in differentiated cells compared to undif-
ferentiated cells using a commercially available kit (Biovision, USA) and by following the manufacturer’s protocol; 
in brief, cells were homogenized in the assay buffer. The homogenized cells were then centrifuged to remove 
insoluble material at 13,000 g for 3 minutes. Then 80 µl of each of the samples was loaded into separate wells of 
a 96 well plate. Then 50 µl of 5 mM of pNPP solution was added to each sample well. Following a mixing step 
by pipetting up and down, the wells were incubated at 25 °C for 60 minutes. A standard curve was generated by 
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diluting 40 µl of 5 mM of pNPP into 160 µl of assay buffer to generate 1 mM pNPP standard. Then 0, 4, 6, 12, 16 
and 20 µl of this standard solution was loaded into a 96 well plate to generate 0–20 nmol/ml pNPP standards 
that could be measured by spectrophotometry. For chondrogenesis, cell pellets were prepared in DMEM/high 
glucose (Sigma) supplemented with 100 nM dexamethasone (DEX), 37.5 μg/ml ascorbate-2-phosphate, 1% (vol/
vol) insulin, transferrin and selenium (ITS-X100; Sigma) and 10 ng/ml transforming growth factor-β1 (TGF-β1) 
(PeproTech, London, UK), and penicillin and streptomycin. Control cultures were treated with DMEM/High 
glucose media with carriers alone, i.e. methanol, sterile water and BSA at appropriate dilutions. At day 28, chon-
drogenic differentiation was examined histologically by fixing the pellets in 10% neutral buffered formalin, then 
embedding in paraffin and cutting tissue sections, which were stained with toluidine blue (Sigma) as a marker of 
proteoglycan synthesis8. In addition, the level of glycosaminoglycan secreted into the differentiating medium in 
the last 24 hours of culture prior to harvesting at day 28 was measured using the DMMB assay. The DMMB assay 
protocol was adapted from the method of Farndale et al., 1986 as follows46: (i) the DMMB dye solution was pre-
pared by adding 3.04 g of glycine, 2.37 g of NaCl and 16 mg of 1,9 DMMB to 1 litre of deionized water; (ii) the pH 
was adjusted to 3.0 with hydrochloric acid and the dye solution was stored in a brown bottle; (iii) 50 μl aliquots of 
culture medium harvested from the cell-seeded scaffolds at day 28 were added in triplicate to a 96 well plate; (iv) 
200 μl of the DMMB dye solution was added to the culture medium and the absorbance was assessed at 540 nm 
immediately. Chondroitin sulphate (CS) from shark cartilage (Sigma) was used to provide a standard curve of 
absorbance (0–40 μg/ml, CS) from which the GAG content in the samples of culture medium was calculated. 
The levels of absorbance for GAG content in the samples of culture medium were normalized to account for the 
background absorbance resultant from the presence of phenol red within the medium by dissolving the standards 
in DMEM medium. For adipogenesis, MSC cultures were maintained in culture media containing 1 μM DEX, 
0.5 mM 3-isobutyl-methylxanthine (Sigma), 1% insulin, transferrin and selenium (ITS-X 100 pre-mix; PAA) and 
100 μM indomethacin (Sigma), for 28 days at 37 °C and 5% CO2, as previously described47. Control cells were 
maintained in complete media with carriers. Differentiation was examined using Oil Red O staining of lipid 
droplets. Cells were fixed in 10% neutral buffer formalin for 1 hour after which the staining solution was added. 
Relative Oil Red O accumulation was measured after treatment with 100% isopropanol for 15 minutes and read-
ing the absorbance of the supernatant at 540 nm using a spectrophotometer.
MSC transplantation into a femoral osteochondral defect model. Following institutional ethical 
review and approval (The Institutional Animal Care and Use Committees of Fukui University, Department of 
Orthopaedics and Rehabilitation Medicine: Approval Number 25–053), female athymic nude rats (F344/N Jcl 
rnu/rnu, CLEA Japan, Inc. Tokyo, Japan) aged 6–10 weeks and weighing 150–170 grams were randomly allocated 
into the following groups: (i) PA MSCs (n = 6 animals); (ii) CD271+ MSCs (n = 6 animals); (iii) a control group 
of Alpha Chondro Shield scaffold alone (no cells, n = 3 animals). These numbers of animals per group have been 
used previously at the same institute to demonstrate significant differences between treatment groups at the 5% 
level48. The rats were anaesthetized by exposure to 3% isoflurane in O2 gas and maintained at 1.5% isoflurane in 
O2 gas during surgery. After sterilising the knees using 70% ethanol, a medial parapatellar skin incision was made 
followed by dissecting through the muscle and then exposing the knee joint by lateral dislocation of the patella. 
Bilateral osteochondral defects of 2 mm diameter and 1 mm depth were created in the patellar groove of the femur 
of each animal using a 2 mm diameter surgical drill. Alpha Chondro Shield was used as the cell carrier/scaffold 
to deliver 5 × 104 PA MSCs or CD271+ MSCs versus no cells (as controls). Prior to transplantation, cells were 
harvested by trypsinisation and seeded in a volume of 10 μl of standard culture medium onto 2 mm diameter 
disks of Alpha Chondro Shield, then incubated in a humidified atmosphere at 37 °C and 5% CO2 for 30 minutes 
to promote cell adherence and incorporation into the scaffold. The cell-seeded and control scaffolds were trans-
planted into the defects and fixed in place with fibrin glue, which was allowed to set for about 10–20 seconds 
(Fig. 6). The patella was relocated, and the connective tissue and skin sutured with nylon sutures. Animals were 
allowed to move freely following recovery and fed a standard maintenance diet and water ad libinum. At 3 weeks 
post-transplantation, animals were sacrificed by overdose of 3% isoflurane to examine the extent of wound repair 
macroscopically and histologically.
Macroscopic scoring of cartilage wound healing. After exposing the knee joint in sacrificed animals, 
the defect was scored macroscopically by two surgeons who were blinded to the treatment arm using an estab-
lished system for assessment of cartilage wound healing in smaller animal models49. The degree of tissue repair 
was scored from 0 points (best outcome) to 4 points (worst outcome) each for: (1) the colour of the repair tissue; 
(2) the extent of blood vessels seen within the repair tissue; (3) the smoothness of the surface of the repair tissue; 
(4) the extent to which the wound defect was filled with repair tissue; (5) the extent of degeneration of the adja-
cent articular cartilage. The scored points for each criterion were added and the degree of best repair was repre-
sented with the lowest score from a total score of 20.
Histological scoring of cartilage wound healing. Following surgical excision, animal knees were fixed 
in 10% neutral buffered formalin (Sigma) for 48 hours and placed in K-CX decalcifying solution (FALMA, Tokyo, 
Japan) for 24–48 hours at 4 °C. Following this, the rat knees were washed overnight in running tap water, pro-
cessed and embedded in paraffin wax blocks ready for sectioning. Tissue sections were cut at 5 microns thickness 
in a standard rotary microtome and these were stained with haematoxylin and eosin (H&E) and toluidine blue 
prior to mounting in DPX and histological examination. The extent and quality of cartilage repair was assessed 
histologically and independently by two examiners using the Wakitani scoring system36, modified to include two 
additional parameters, i.e. to examine the presence of blood vessels and foreign body giant cells (FBGCs). Hence, 
the scoring system comprised of seven different parameters: (1) cell morphology; (2) matrix staining; (3) surface 
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regularity; (4) thickness of cartilage; (5) integration of the repair tissue with host cartilage; (6) the extent of vas-
cularisation within the defect; (7) the extent of FBGC reaction. For each of these parameters, the lowest score (0) 
represented the ‘best’ repair and a highest score (4) represented the ‘worst’ repair. The overall scores were added 
and then compared between groups out of a total score of 21.
Immunohistochemistry for human mitochondrial antigen. Tissue sections were stained with an 
anti-human mitochondrial antigen (HMA) antibody (Clone 113-1: Abcam, Cambridge, UK) to assess the pres-
ence of human MSCs. Following antigen retrieval, the sections were immersed in three changes of PBS and 
blocked for 20 minutes with 2.5% horse serum (Vector Labs Ltd) at room temperature to prevent non-specific 
binding. The sections were then incubated with the mouse anti-HMA antibody (1:400 dilution in PBS) for 1 hour 
at room temperature in a humidified chamber. Following this, any unbound antibody was washed off in three 
changes of PBS gently and the sections were incubated with biotinylated anti-mouse IgG for 30 minutes at room 
temperature. The sections were washed three times in PBS and endogenous peroxidise activity was blocked 
using 0.3% hydrogen peroxide in methanol for 30 minutes at room temperature. During this incubation step, 
the Vecta ABC regent (Vector Labs Ltd, Peterborough, UK) was prepared and was allowed to stand for 30 min-
utes before use as per the manufacturer’s instructions. After blocking the endogenous peroxidise activity, sec-
tions were washed in three times PBS and incubated with the ABC reagent for 30 minutes at room temperature. 
Following this, a DAB chromogen (Vector labs) was added for 6–8 minutes depending on the intensity of colour 
desired. Sections were then washed and dehydrated through series of ethanol (70–100%), cleared with xylene 
and mounted in Pertex. Chondrogenic pellet of human MSCs was used as a positive control. Negative control 
included chondrogenic pellet where the primary antibody was omitted.
Scanning electron microscopy. The adhesion of MSCs seeded into the Alpha Chondro Shield scaffold 
prior to implantation was examined by scanning electron microscopy (SEM) as follows: after the cell-seeded 
scaffolds had been incubated in a humidified atmosphere at 37 °C and 5% CO2 for 30 minutes, they were washed 
in PBS and then fixed in 2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 hours, then washed in 
0.1 M phosphate buffer prior to treatment with 1% osmium tetraoxide for 1 hour. The samples were then dehy-
drated through a graded series of ethanol solution, treated with transition solvent, t-butyl alcohol for 30 minutes, 
freeze-dried, coated with gold palladium and finally imaged using a JSM-6390 (JEOL, Tokyo, Japan) or Zeiss 
EVO10 scanning electron microscope (Carl Zeiss, Cambridge, UK).
LIVE/DEAD staining to assay cell viability in cell-seeded scaffolds. MSC-seeded scaffolds were 
stained with LIVE/DEAD staining solution following the manufacturer’s protocol, as described previously8. 
Briefly, the cell-seeded scaffolds were immersed in the LIVE/DEAD staining solution for 30 minutes in the dark 
at 37 °C. The scaffolds were then removed from the staining solution, washed in PBS and immediately imaged 
using a confocal microscope (Leica Microsystems DM6000B – SP57CS).
In vitro angiogenesis assays. The human EA.hy926 endothelial cell line was used as a model to exam-
ine any angiogenic activity of culture conditioned medium from PA MSC and CD271+ MSC CM. EA.hy926 
Figure 6. The procedure of MSC transplantation into full-thickness osteochondral defects. Scaffolds were cut 
into 2 mm diameter sized disks and were sterilised using UV prior to cell-seeding. Culture-expanded PA MSCs 
and CD271-selected MSCs were trypsinised and seeded onto the Alpha Chondro Shield scaffold using a simple 
pipetting technique in a volume of 10 µl. Subsequently, the cell-seeded scaffolds were transplanted into the 
defects and fixed in place using fibrin glue.
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endothelial cell proliferation/migration and endothelial tubule formation were examined as follows: (i) EA.hy926 
cells were cultured in standard culture medium (DMEM/ F-12 supplemented with 10%FBS, 1% penicillin and 
streptomycin) in 24 well plates for 2 days until 100% confluent monolayers formed. A sterile pipette tip was 
used to make a scratch in the monolayer. Subsequently, the wells were washed with sterile PBS and then 1 ml 
of conditioned media from PA MSC cultures or CD271+ MSC cultures was added into each of triplicate wells 
per condition tested. Serum-free DMEM culture medium was used as a control. The plate was incubated in the 
Cell IQ platform for live cell digitized imaging over a 2 day period, after which scratch wound closure, viable cell 
numbers and the extent of migration of individual cells were quantitated using the Cell IQ image analysis soft-
ware. The proliferative response of EA.hy926 endothelial cells to PA MSC And CD271+ MSC conditioned media 
(versus serum-free control medium) was also examined using the MTT assay; (ii) EA.hy926 endothelial tubule 
formation was tested using growth factor-reduced Matrigel (BD Bioscience), which was aliquoted into 96-well 
plates (50 μl Matrigel/well) and then incubated for 30 min at 37 °C. EA.hy926 endothelial cells were seeded onto 
the Matrigel at 2 × 104 cells/well in 200 µl of PA MSC and CD271+ MSC conditioned media or serum-free control 
culture medium. The plates were incubated at 37 °C for 1 day, after which they were imaged using Cell IQ imaging 
platform (3 images per well). The total endothelial tubule length/image and total number of endothelial tubule 
branching points/image were measured using the Cell IQ image analyser software.
Statistical analysis. Statistical analysis was performed using GraphPad Prism6 software (GraphPad 
Software, Inc. CA, USA). For in vivo experiments, a minimum of n = 3 animals per condition were tested. For in 
vitro experiments, n = 3–4 independent experiments were performed for all analyses, where data were analysed 
with one-way ANOVA when there was one variable factor, and two-way ANOVA when there were two variable 
factors. For macroscopic and histological scores of cartilage repair, differences between groups were examined 
using Dunn’s multiple comparison tests. A p value of less than 0.05 was considered significant. All data has been 
presented as means ± SEMs or means ± SDs (as indicated in the figure legends).
Data Availability
Data generated and analysed during this study are included in this published article. Data and materials are avail-
able from the corresponding author subject to reasonable request and subject to the ethical approvals in place and 
material transfer agreements.
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